Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Heska Corp (HSKA)

Heska Corp (HSKA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,309,570
  • Shares Outstanding, K 10,914
  • Annual Sales, $ 257,310 K
  • Annual Income, $ -19,890 K
  • 60-Month Beta 1.58
  • Price/Sales 5.09
  • Price/Cash Flow 70.99
  • Price/Book 3.14
Trade HSKA with:
  • Price/Earnings ttm 315.63
  • Earnings Per Share ttm 0.38
  • Most Recent Earnings $0.17 on 05/05/23
  • Latest Earnings Date 05/08/23
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend 0.100 on 09/26/12
  • Sectors:

Options Overview Details

View History
  • Implied Volatility 0.00% ( unch)
  • Historical Volatility 10.75%
  • IV Percentile 0%
  • IV Rank N/A
  • IV High 0.00% on N/A
  • IV Low 0.00% on N/A
  • Put/Call Vol Ratio N/A
  • Today's Volume N/A
  • Volume Avg (30-Day) N/A
  • Put/Call OI Ratio N/A
  • Today's Open Interest N/A
  • Open Int (30-Day) N/A

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/23
See More
  • Average Estimate 0.16
  • Number of Estimates 2
  • High Estimate 0.16
  • Low Estimate 0.15
  • Prior Year -0.02
  • Growth Rate Est. (year over year) +900.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
115.42 +3.96%
on 05/26/23
120.03 -0.03%
on 06/12/23
+2.87 (+2.45%)
since 05/12/23
3-Month
80.16 +49.69%
on 03/13/23
120.03 -0.03%
on 06/12/23
+37.70 (+45.81%)
since 03/10/23
52-Week
57.83 +107.48%
on 01/06/23
120.03 -0.03%
on 06/12/23
+28.52 (+31.18%)
since 06/10/22

Most Recent Stories

More News
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates HSKA, TESS, NATI, STSA

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

HSKA : 119.99 (+0.04%)
TESS : 8.99 (+0.11%)
NATI : 59.98 (unch)
STSA : 1.1000 (-0.90%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates HSKA, NATI, TESS, DHC

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

HSKA : 119.99 (+0.04%)
NATI : 59.98 (unch)
TESS : 8.99 (+0.11%)
DHC : 2.42 (-1.22%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates HSKA, TESS, NATI, STSA

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

HSKA : 119.99 (+0.04%)
TESS : 8.99 (+0.11%)
NATI : 59.98 (unch)
STSA : 1.1000 (-0.90%)
Heska (HSKA) Q1 Earnings and Revenues Lag Estimates

Heska (HSKA) delivered earnings and revenue surprises of -46.88% and 7.10%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

HSKA : 119.99 (+0.04%)
PGEN : 1.3900 (-2.80%)
Heska: Q1 Earnings Snapshot

Heska: Q1 Earnings Snapshot

HSKA : 119.99 (+0.04%)
Heska Corporation Reports First Quarter 2023 Results

/PRNewswire/ -- Heska Corporation (NASDAQ: HSKA; "Heska" or "Company"), a leading global provider of advanced veterinary diagnostic and specialty products,...

HSKA : 119.99 (+0.04%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates USX, HSKA, TRTN

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

USX : 6.14 (unch)
HSKA : 119.99 (+0.04%)
TRTN : 79.55 (-4.10%)
Moore Kuehn Encourages HOTH, HSKA, SPPI, and GLOP Investors to Contact Law Firm

/PRNewswire/ -- Moore Kuehn, PLLC, a law firm focusing in securities litigation located on Wall Street in downtown New York City, is investigating potential...

HOTH : 1.1500 (-0.86%)
HSKA : 119.99 (+0.04%)
SPPI : 1.0300 (unch)
GLOP : 8.63 (-0.12%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates UNVR, HSKA, TRTN, TESS

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

UNVR : 36.14 (+0.47%)
HSKA : 119.99 (+0.04%)
TRTN : 79.55 (-4.10%)
TESS : 8.99 (+0.11%)
Heska Announces Annual Meeting of Stockholders on May 3, 2023

/PRNewswire/ -- Heska Corporation (NASDAQ: HSKA; "Heska" or the "Company"), a leading global provider of advanced veterinary diagnostic and specialty...

HSKA : 119.99 (+0.04%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is in highly overbought territory. Beware of a trend reversal.

See More Share

Business Summary

Heska Corporation sells advanced veterinary diagnostic and specialty products. Heska's state-of-the-art offerings include blood testing instruments and supplies, digital imaging products, software and services, data services, allergy testing and immunotherapy, and single-use offerings such as in-clinic...

See More

Key Turning Points

3rd Resistance Point 120.10
2nd Resistance Point 120.06
1st Resistance Point 120.03
Last Price 119.99
1st Support Level 119.96
2nd Support Level 119.92
3rd Support Level 119.89

See More

52-Week High 120.03
Last Price 119.99
Fibonacci 61.8% 96.27
Fibonacci 50% 88.93
Fibonacci 38.2% 81.59
52-Week Low 57.83

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar